fda semaglutide compounding is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Novo asks FDA to prevent

That stress disrupts the hair growth cycle, pushing more hairs into the shedding (telogen) phase while fewer new ones grow in

While trezepatide shows a slight edge in weight loss and potential cardiovascular benefits, the choice ultimately depends on individual patient needs

However, these animal findings are concerning enough that drug manufacturers and regulatory agencies have recommended caution until we have better human data

Free radicals are unstable molecules that can damage cells, leading to inflammation and oxidative stress

Get safe, trusted care from home, on your schedule, without the stress

Novo Nordisk said in an email to CNN that it has been in ongoing dialogue with the FDA regarding the manufacturing and supply of Wegovy and Ozempic, and the company has remained confident in its supply since the shortage ended